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Calcyclin, a eel1 cycle regulated protein, was recently purified from Ehrlich ascites tumour (EAT) cells and shown to be a calcium binding protein. 
Here we show that calcyclin monomer and dimer also bind zinc ions. Zinc binding sites seem to be different from calcium binding sites since: 
preincubation with Ca2+ lacks effect on the binding of ZnZ+, and Car+ (but not Znr+) increases tyrosine fluorescence intensity. Binding of Znr+ 
reduces the extent of the conformational changes induced by Caz*, and seems to affect Ca2+-binding. The data suggest hat Car+ and Znr+ might 
trigger the biological activity of calcyclin. 
Calcyclin; Calcium-binding protein; Zinc-binding protein 
1. INTRODUCTION 
Calcyclin is the name that was given to a gene 
originally identified as a cDNA clone (2A9) whose 
cognate RNA is growth regulated [I ,2]. The steady- 
state levels of cytoplasmic mRNA recognized by a 
calcyclin probe increase when quiescent fibroblasts are 
stimulated to proliferate by either serum, platelet- 
derived growth factor or epidermal growth factor. The 
level of calcyclin mRNA also increases in human acute 
myeloid leukemia and it was suggested that calcyclin is 
involved in the control of cell proliferation [3]. Also, it 
was deduced from cDNA sequence that calcychn con- 
tains the EF-hand structural elements, which suggested 
calcium binding. This suggestion was confirmed when 
calcyclin was purified from EAT cells and directly 
shown to bind calcium ions [4,5]. It was also shown 
that the expression of calcyclin is tissue- and cell- 
specific [6]. The calcyclin cDNA sequence has strong 
homology to the sequences of the S-100 proteins and to 
the pll (pll is a subunit of the complex that serves as 
a cellular substrate for tyrosine kinase (reviewed in 171). 
We showed earlier, that calcyclin, similarly to S-100 
protein, formed dinners [5]. Since the,& subunit of S-100 
binds Zn*+ and the binding sites are different from the 
Cazf-binding sites [S,9] we investigated if calcyclin has 
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similar properties. We found that calcyclin is a 
Zn’+-binding protein and demonstrated that Zn2+- and 
Ca2+-binding sites are located differently at the 
calcyclin molecule. 
2. MATERIALS AND METHODS 
2.1. Proteins 
Calcyclin was isolated from EAT cells and monomers and dimers 
were separated by HPLC [4,5]. Calmodulin and S-100 proteins (a 
mixture of (Y and p subunits) were purified from bovine brain [IO] 
and parvalbumin from rat muscle 1111. Protein concentration was 
estimated as described in [i2]. 
2.2. Polyacrylamide gel electrophoresis and blotting 
The details on tricine-SDS-polyacrylamide (15%) gel elec- 
trophoresis [13] and on electrophoretic transfer [14] are given in our 
earlier paper [5]. 
2.3. 6fZinc- and “catciam-tra~h~ot e~ectrophor~is 
After the transfer of proteins onto nitr~ellulose, the filters were 
washed in a buffer containing 50 mM NaCl, 100 mM Tris-HCl, pH 
7.5, for at least 1 h [IS]. The nitrocellulose filters were incubated for 
15 min with 1OpCi of 65ZnC1r (2 Ci/g, DuPont de Nemours, FRG) 
in 20 ml of the above buffer. The filter was washed with the same 
buffer containing no Zn *+ for 15 min with two changes. In competi- 
tion experiments, divalent metal ions were included in the buffer dur- 
ing all steps. Autoradiographs were exposed to Rentgen-XS films 
(Organika-Foton, Poland) for 7-14 days at -70°C. “Calcium- 
transblot was done as in 1161. 
2.4. Fluorescence measurements 
The effect of Ca’+ and Zn’+ on tyrosine fluorescence intensity of 
calcyclin was examined using a Perkin-Elmer MPF-2L spec- 
trofluorimeter, at 20°C. Tyrosine fluorescence was monitored at 
304 nm, with excitation at 276 nm. Calcyclin was decalcified as 
described in [4]. 
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3. RESULTS 
Fig. 1 shows the autoradiographs of the blots in- 
cubated with either radioactive Ca’+ (Fig. 1A) or Zn’+ 
(Fig. lB,C). All proteins tested (calmodulin, par- 
valbumin, calcyclin and S-100) bound Ca*+ , but only 
calcyclin and S-100 bound Zn*+. There is more 65Zn2+ 
in the S-100 track than in the calcyclin track, because 
different amounts of the proteins were present in the 
gel and because there is slightly lower binding of Zn*+ 
by calcyclin than by S-100 protein (see Fig. 2, where 
similar amount of both proteins was used). 
Calcyclin forms dimers by S-S bridges that are visi- 
ble on SDS-polyacrylamide gels without 2-mercapto- 
ethanol. Fig. 1C shows that calcyclin monomer as well 
as its dimers bind Zn*+ .
The ability of Zn*+ to bind to the proteins immobiliz- 
ed on nitrocellulose depends on the pH of the binding 
buffer. Therefore we examined the Zn*+ binding to 
calcyclin, calmodulin and S-100 protein at pH 6.8, 7.5 
and 8.0. Autoradiography of the probed filters revealed 
that calcyclin and S-100 bound Zn*+ not only at pH 7.5 
(Fig. l), but also at pH 6.8 and pH 8.0 (not shown). 
The intensity of Zn*+ signal was higher at pH 8.0 than 
at pH 6.8, but calmodulin did not bind Zn*+ at any pH 
(shown at pH 7.5; Fig. 1B). 
Divalent metal ions such as Cd*+ can replace Zn*+ 
ions in several zinc binding proteins (reviewed in [17]). 
Therefore we examined the ability of cadmium ions to 
compete with 65Zn2+ in the zinc overlay assay (Fig. 2). 
Nitrocellulose filters containing calcyclin and S-100 
protein were equilibrated for 1 h with a buffer contain- 
ing 0.1 mM CdCh. The filters were then incubated with 
65ZnC12 plus competitor and washed in a buffer that 
contained the competitor alone. The autoradiographs 
from such experiments howed that Cd*+ significantly 
decreased binding of Zn*+ to both proteins, but 
Zn*+-binding by S-100 protein was more efficiently in- 
hibited by Cd*+ (Fig. 2B). In contrast, Ca*+ at the same 
concentration (0.1 mM), did not compete with “Zn*+ 
in binding to calcyclin or S-100 (not shown), and at 
10 mM had only smail effect, probably due to the non- 
specific binding (Fig. 2C). 
Ca*+ binding to calcyclin induces conformational 
changes that can be measured by an increase of the in- 
trinsic tyrosine fluorescence [4]. Calcyclin contains 3 
tyrosine residues (Fig. 3). Tyrosine 18 and 72 are near 
the first and second Ca*+ binding site, respectively, and 
both may be responsible for the Ca*+-induced changes 
in fluorescence intensity. To check if Zn*+ binds to dif- 
ferent sites in the calcyclin molecule, we studied the ef- 
fect of each cation on the tyrosine fluorescence 
intensity. When Zn*+ was added to the apo-protein 
there was no increase in the fluorescence intensity 
unless Ca*+ was added (Fig. 4).‘Upon Ca*” saturation 
in the presence of Zn *+ there was 17% increase of the 
fluorescence intensity. When Ca*+ was added in the 
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Fig. 1. 65ZnZ+ and ‘?a’+ binding on nitrocelhtlose. The proteins 
were separated on polyacrylamide gels and transferred to 
nitrocellulose. The blots were incubated with either radioactive 
calcium (A) or zinc (B, C) (at pH 7.3, and autoradiographed for 5 
days (A) or 14 days (B, C). A, B: (a) 8 pg of bovine brain calmodulin; 
(b) 6 pg of rat muscle parvalbumin; (c) 7.5 pg of EAT cells calcyclin; 
(d) 19 yg of bovine brain S-100 protein. C: (e) 18 cg of calcyclin 
dimer and monomer; (f) 9 pg of calcyclin monomer; (g) 9pg of 
calcyclin dimer .
absence of Zn*+ the fluorescence intensity increased up 
to 26%. Subsequent addition of Zn*+ partly (about l/3 
of the increase) decreased the level of fluorescence in- 
tensity (Fig. 4). These results and those in Fig. 3 sug- 
gested that Ca*+ and Zn*+ may bind to the different 
sites at the molecule. 
Ca*+ binding parameters were measured in the 
absence or presence of 0.1 mM ZnCl2 by titration of 
the fluorescence intensity of calcyclin with increasing 
concentrations of Ca*+ (see [4] for details). Both titra- 
tion curves exhibited an end-point at a Ca*+/protein 
ratio of about 1.7 suggesting the binding of 2 calcium 
ions (not shown). 
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Fig. 2. Zn2+ binding in the presence of Cd*+ or Ca’+. 
Autoradiographs (14 days) of the nitrocellulose filters containing 
7.5 pg of calcyclin (1) and 8.5 pg of S-100 protein (2) after incubation 
with 65ZnC12. The control filters (A) were preincubated in a buffer 
containing no cations added, incubated in a buffer containing 65Zn2+ 
and washed with a buffer containing no cations. (B, C) The filters 
were preincubated in buffers containing competitive metal ion (B, 
0.1 mM CdCl2; C, 10 mM CaClz), incubated in a buffer containing 
‘sZnCl2 plus the same concentration of competing ion, and next 
washed with buffers containing CdCl2 or CaCl2, respectively. 
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Fig. 3. Schematic structure of calcyclin. The plausible Ca ” binding sites (I and II) are drawn as the loops. Only tyrosine residues (Y) and the 
amino acids that could participate in Zn2+ -binding are shown by the letters: C, cysteine; D, aspartate; E, glutamate; H, histidine. Other amino 
acids are shown by dashes. The numbers refer to the position of amino acids in cDNA-derived protein sequence of human calcyclin 121. 
[MeCl2] mM 
Fig. 4. Changes in tyrosine fluorescence intensity of calcyclin in the 
presence of Ca2+, Zn2+ or both. Tyrosine fluorescence intensity of 
decalcified calcyclin was monitored: upon addition of CaClr (open 
circles) and subsequent addition of ZnClr (closed circles) (one line); 
or (second line) after addition of both cations in the opposite order. 
The [MeClz] shows the total concentration of CaC12 and ZnCl2 
added. 
4. DISCUSSION 
In this report we showed that calcyclin, similarly to 
S-100 protein, binds Zr?. The binding is specific, since 
other calcium binding proteins such as calmodulin or 
parvalbumin did not bind Zn2+ under the same condi- 
tions. Calcyclin seems to have lower affinity for Zn2+, 
and/or lower number of Zn2+-binding sites than S-100 
protein. Because Cd’+ displaces Zn2+ less efficiently 
from calcyclin, than from S-100 protein, we suggest 
that these proteins have different affinities for cad- 
mium ions. 
Competition binding experiments on nitrocellulose 
(Fig. 2C) and the observation that Zn2+ binding to apo- 
protein does not induce the conformational changes 
characteristic for Ca2+ (Fig. 4) seems to suggest hat 
Zn2+ binds to the sites different from those engaged in 
Ca2+ binding. Since the extent of Ca’+-induced changes 
of tyrosine fluorescence intensity depends on the 
presence of Zn’+, it might be that Ca’+-calcyclin com- 
plex has different conformation than that of 
Ca’+-Zn’+-calcyclin. The results also suggest that 
Zn2+-binding may affect Ca2+-binding. We calculated 
from the titration curves that, despite Zn2+ presence, 
the number of calcium ions bound to calcyclin (2 ions) 
and the calculated product (8 x lo-l2 M2) of both 
dissociation constants are the same. It is impossible to 
estimate from this value the dissociation constant for 
each site since they have different affinities for Ca’+. 
The results in Fig. 4 also may suggest hat apparent 
cooperativity of Ca2+-binding site(s) changes upon 
Zn2+-binding to another scheme of binding. 
The question arises where the zinc binding sites are 
located in the calcyclin molecule and what their struc- 
ture is? There are several different ways in which Zn2+ 
could interact with proteins (reviewed in [ 171). The first 
one involves interaction of the cation with residues 
located in a short segment of a protein that contains 
pairs of closely spaced cysteine and histidine residues or 
clusters of cysteine residues forming so called ‘zinc 
fingers’. Human calcyclin contains only one cysteine 
(position 2) and two histidine residues (16 and 26) and 
therefore it is unlikely that they could form a ‘finger’ 
(Fig. 3). The second type of structure to bind Zn2+ has 
been described as the clusters of 4-12 acidic amino acid 
residues [ 181, but there are no such clusters in the 
calcyclin molecule (Fig. 3). A third possibility is an in- 
teraction of Zn2+ with residues distantly located from 
each other in the primary sequence that form a struc- 
tural element called a ‘conformation’ site (reviewed in 
[19]). It is possible that such a site may be responsible 
for binding of Zn2+ to calcyclin, but this must be fur- 
ther investigated. 
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